trihexyphenidyl has been researched along with Sclerosis, Systemic in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROBINSON, HM | 1 |
| CORDERO, AA | 1 |
| CORTI, RN | 1 |
2 other studies available for trihexyphenidyl and Sclerosis, Systemic
| Article | Year |
|---|---|
Artane in the treatment of morphea and scleroderma; a preliminary report.
Topics: Humans; Scleroderma, Localized; Scleroderma, Systemic; Trihexyphenidyl | 1952 |
[Artane in the treatment of scleroderma].
Topics: Humans; Scleroderma, Systemic; Trihexyphenidyl | 1953 |